FEDERALhearing transcript

Congressional Hearing on Health Care Apps

Original title: THE DISRUPTER SERIES: HEALTH CARE APPS

January 1, 2017

health care mobile applications medical technology regulation digital health

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing explored how mobile health technology impacts patient data privacy, medical accuracy, and the regulatory oversight required to ensure safety for consumers using health-related apps.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Health care app developers

The regulatory environment discussed in the hearing directly impacts the standards and requirements for developing and marketing health apps.

Patients

Patients using health apps are affected by the accuracy, privacy, and clinical utility of the tools discussed.

Medical professionals

Doctors and clinicians are affected by the integration of app-based data into their diagnostic and treatment processes.

What changed

Last recorded activity January 1, 2017.

What's next

Next step not available in the current record.

Summary

This document is a transcript record of a 2016 House subcommittee hearing regarding the rise of health care mobile applications. Lawmakers and industry experts discussed the potential for these apps to improve patient care and the challenges of regulating them.

Key Facts

The hearing was held on July 13, 2016, by the Subcommittee on Commerce, Manufacturing, and Trade.
The session was part of the 'Disrupter Series,' focusing on the impact of new technologies on existing markets.
Witnesses included representatives from medical technology companies, academic medical centers, and legal experts.
The discussion covered the integration of mobile apps into clinical practice and patient monitoring.
Several organizations, including Fitbit, the American Medical Association, and the Consumer Technology Association, submitted written statements for the record.

Why It Matters

The hearing explored how mobile health technology impacts patient data privacy, medical accuracy, and the regulatory oversight required to ensure safety for consumers using health-related apps.

Frequently Asked Questions

What was the purpose of this hearing?

The hearing was held to examine the role of mobile health applications in the modern health care system and to discuss how these technologies are changing patient care.

Who testified at the hearing?

Witnesses included experts from Humetrix, the University of Pittsburgh, the University of Rochester Medical Center, Johnson & Johnson, Indiana University, and Airstrip.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Early Digital Health Oversight

The hearing highlights the transition period in 2016 where Congress began actively evaluating how to apply traditional medical device regulations to software applications.

House Committee on Energy and Commerce

Connected Entities

organizationJohnson & Johnson“Represented by Diane Johnson”Map →

personJanice D. Schakowsky“Ranking Member of the Subcommittee”Map →

personMichael C. Burgess“Chairman of the Subcommittee on Commerce, Manufacturing, and Trade”Map →

organizationFitbit“Submitted a statement for the record”Map →

organizationAmerican Medical Association“Submitted a statement for the record”Map →

organizationHumetrix“Represented by CEO Dr. Bettina Experton”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance40
How much this matters to a regular citizen
Controversy20
Intensity of disagreement among stakeholders
Entertainment10
Compellingness for a non-policy-wonk reader
Buzz5
Current news / social attention level

Publisher tools